Treatment of Henoch-Schönlein Purpura with Extensive, Rapidly Progressing Purpuric Skin Rash
When Henoch-Schönlein purpura presents with an extensive, rapidly progressing purpuric skin rash, the clinical picture warrants a structured, evidence-informed management approach tailored to the severity and pace of cutaneous involvement.
Clinical Scenario
Extensive, rapidly progressing purpuric skin involvement represents a more severe cutaneous manifestation of Henoch-Schönlein purpura. The pace and extent of rash progression are key factors that influence treatment selection for this presentation.
Treatment Approach — Partial Overview
The protocol involves specific immunomodulatory agents, with individual agent selection guided by the patient’s clinical history and relevant pre-treatment assessments. Different patient factors — including associated symptoms and baseline organ function — determine which option is most appropriate. The complete regimen, selection criteria, and clinical considerations are available in the full structured protocol.
References
- Extensive rapidly progressing rash may be an indication to use short course of steroids.
- Azathioprine can be used in patients who resisted to steroid therapy.
- Colchicine may be used if associated with history suggestive of auto-inflammation or if associated with severe abdominal pain.
- Dapsone (after checking for history suggestive of G6PD deficiency) can be used in severe cases, with consideration to the kidney function status.
View source ↗